Major depression (MD) is a leading cause of global disease burden, and both experimental and population-based studies suggest that differences in DNA methylation may be associated with the condition.

Learn more about a clinical trial examining a potential new treatment for depression in adult patients. Managing symptoms of depression can feel overwhelming, but you are not alone. If you experience ...

Since its discovery by Leão in 1944 (ref. 1), spreading depression has perplexed neurologists, neurosurgeons and neuroscientists alike. From the first description in rabbits to its detection in ...

SAN ANTONIO, May 27, 2026 /PRNewswire/ -- A peer-reviewed case study published in the journal Transcranial Magnetic Stimulation reports that an accelerated transcranial magnetic stimulation (aTMS) ...

A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of depression and anxiety is staggering. The study found that 40% of adults with ...

A single dose of psychedelics significantly reduced symptoms in people with major depressive disorder, a new study found. The clinical trial was led by researchers at Imperial College London, where ...

Researchers say standard depression screening tools often check for physical symptoms, but weren't designed for those with cancer ...

Depression is one of the leading causes of disability worldwide, affecting around 322 million people, yet it remains a complex and poorly understood condition. About 15 percent of the global ...

Transcranial magnetic stimulation (TMS, or "rTMS" for "repetitive TMS") received an indication for treating major depressive disorder in 2008. Since then, research and clinical experience with TMS has ...